about
Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices.Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS.Bio-inspired solid phase extraction sorbent material for cocaine: a cross reactivity study.Screening of methylenedioxyamphetamine- and piperazine-derived designer drugs in urine by LC-MS/MS using neutral loss and precursor ion scan.Micro extraction by packed sorbent coupled to liquid chromatography tandem mass spectrometry for the rapid and sensitive determination of cannabinoids in oral fluids.A new multi analytical approach for the identification of synthetic and natural dyes mixtures. The case of orcein-mauveine mixture in a historical dress of a Sicilian noblewoman of nineteenth century.Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation.Determination of illicit drugs and metabolites in oral fluid by microextraction on packed sorbent coupled with LC-MS/MS.A μ-SPE procedure for the determination of cannabinoids and their metabolites in urine by LC-MS/MS.Pressurized liquid extraction for the determination of cannabinoids and metabolites in hair: Detection of cut-off values by high performance liquid chromatography-high resolution tandem mass spectrometry.Validation of a method for the targeted analysis of 96 drugs in hair by UPLC–MS/MSFatty acid composition and δ13C of bulk and individual fatty acids as marker for authenticating Italian PDO/PGI extra virgin olive oils by means of isotopic ratio mass spectrometryNeutral loss and precursor ion scan tandem mass spectrometry for study of activated benzopyrene–DNA adductsSimultaneous determination of lamivudine, lopinavir, ritonavir, and zidovudine concentration in plasma of HIV-infected patients by HPLC-MS/MS
P50
Q38161854-C180E5FA-0750-41D3-8FD4-1EB89CD068F0Q44358214-98EF9524-FE3F-421F-AA52-11D28DD1D29FQ44416089-C3D71E04-1929-43B8-9DDB-E734D0EFCF98Q44758844-873CE34D-DD0A-4EBC-9BB5-303DE3FA1520Q45155623-B7287986-73D5-4EEA-9663-C6E8EFB62A7AQ47176851-9BDB2980-4EB9-4AA7-85A7-C1F061EFBA00Q49556857-6F538D15-954F-4682-B898-F0D834F04ABDQ50593926-F52EF61C-AA7E-4F30-8D11-580A7F8A7796Q53069764-73DBA2E7-8B35-481B-AF87-8AD64C89AF88Q53450720-98C8F595-8D08-45BA-BCA4-F5A70FE291A4Q58444686-F7A597D1-E8DE-46A1-8E8F-743BCBBA5167Q58831880-3A7514A4-25AE-4A4B-89E7-A901346EF2BBQ58831916-57FC79E3-D0A1-4871-A8E8-9F9A7DAA56B4Q62206137-31E38996-25FF-4304-9A3F-E5F2DB614F33
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Camilla Montesano
@ast
Camilla Montesano
@en
Camilla Montesano
@es
Camilla Montesano
@nl
Camilla Montesano
@sl
type
label
Camilla Montesano
@ast
Camilla Montesano
@en
Camilla Montesano
@es
Camilla Montesano
@nl
Camilla Montesano
@sl
prefLabel
Camilla Montesano
@ast
Camilla Montesano
@en
Camilla Montesano
@es
Camilla Montesano
@nl
Camilla Montesano
@sl
P106
P1153
36669006100
P21
P31
P496
0000-0001-7721-4961